Back to top

stock-price-change: Archive

Zacks Equity Research

Bears are Losing Control Over Cartesian Therapeutics, Inc. (RNAC), Here's Why It's a 'Buy' Now

Cartesian Therapeutics, Inc. (RNAC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

RNACPositive Net Change

Zacks Equity Research

Bears are Losing Control Over Sana (SANA), Here's Why It's a 'Buy' Now

Sana (SANA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

SANANegative Net Change

Zacks Equity Research

Moog (MOG.A) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Moog (MOG.A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MOG.APositive Net Change WWDNegative Net Change

Zacks Equity Research

Here's Why InflaRx (IFRX) Is a Great 'Buy the Bottom' Stock Now

InflaRx (IFRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

IFRXNegative Net Change

Zacks Equity Research

Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

DCTHNegative Net Change

Zacks Equity Research

Analysts Estimate Valvoline (VVV) to Report a Decline in Earnings: What to Look Out for

Valvoline (VVV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VVVNegative Net Change

Zacks Equity Research

Gap (GAP) Earnings Expected to Grow: Should You Buy?

Gap (GAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GAPPositive Net Change

Zacks Equity Research

Esco Technologies (ESE) Earnings Expected to Grow: Should You Buy?

Esco Technologies (ESE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ESENegative Net Change

Zacks Equity Research

Earnings Preview: Grandstand Limited (GRSD) Q3 Earnings Expected to Decline

Grandstand Limited (GRSD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GRSDNegative Net Change

Zacks Equity Research

Bath & Body Works (BBWI) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Bath & Body Works (BBWI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BBWINegative Net Change